Viewing Study NCT06726161

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:49 AM
Ignite Modification Date: 2026-01-27 @ 4:11 AM
Study NCT ID: NCT06726161
Status: RECRUITING
Last Update Posted: 2025-05-25
First Post: 2024-11-05
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ Unresectable HCC
Sponsor: RayzeBio, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HCC View
Keywords:

Keywords

Keyword Brief Keyword Text View
None actinium View
None theranostic View
None alpha-emitter View
None RYZ811 View
None RYZ801 View
None 225Ac View
None HCC View
None targeted radiotherapy View
None radiopharmaceutical View
None unresectable HCC View